Abstract
Summary
LPI (LP Information)' newest research report, the “Solid Phase Peptide Synthesizers (SPPS) Industry Forecast” looks at past sales and reviews total world Solid Phase Peptide Synthesizers (SPPS) sales in 2022, providing a comprehensive analysis by region and market sector of projected Solid Phase Peptide Synthesizers (SPPS) sales for 2023 through 2029. With Solid Phase Peptide Synthesizers (SPPS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Solid Phase Peptide Synthesizers (SPPS) industry.
This Insight Report provides a comprehensive analysis of the global Solid Phase Peptide Synthesizers (SPPS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid Phase Peptide Synthesizers (SPPS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Solid Phase Peptide Synthesizers (SPPS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid Phase Peptide Synthesizers (SPPS) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid Phase Peptide Synthesizers (SPPS).
The global Solid Phase Peptide Synthesizers (SPPS) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Solid Phase Peptide Synthesizers (SPPS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Solid Phase Peptide Synthesizers (SPPS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Solid Phase Peptide Synthesizers (SPPS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Solid Phase Peptide Synthesizers (SPPS) players cover Büchi AG, AAPPTec, CEM, Gyros Protein Technologies, Biotage and CSBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid Phase Peptide Synthesizers (SPPS) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Automated
Semi-automatic
Segmentation by application
Pharmaceutical Industry
Chemical Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Büchi AG
AAPPTec
CEM
Gyros Protein Technologies
Biotage
CSBio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Solid Phase Peptide Synthesizers (SPPS) market?
What factors are driving Solid Phase Peptide Synthesizers (SPPS) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Solid Phase Peptide Synthesizers (SPPS) market opportunities vary by end market size?
How does Solid Phase Peptide Synthesizers (SPPS) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Solid Phase Peptide Synthesizers (SPPS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Solid Phase Peptide Synthesizers (SPPS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Solid Phase Peptide Synthesizers (SPPS) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Solid Phase Peptide Synthesizers (SPPS) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Solid Phase Peptide Synthesizers (SPPS).
The global Solid Phase Peptide Synthesizers (SPPS) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Solid Phase Peptide Synthesizers (SPPS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Solid Phase Peptide Synthesizers (SPPS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Solid Phase Peptide Synthesizers (SPPS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Solid Phase Peptide Synthesizers (SPPS) players cover Büchi AG, AAPPTec, CEM, Gyros Protein Technologies, Biotage and CSBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Solid Phase Peptide Synthesizers (SPPS) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Automated
Semi-automatic
Segmentation by application
Pharmaceutical Industry
Chemical Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Büchi AG
AAPPTec
CEM
Gyros Protein Technologies
Biotage
CSBio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Solid Phase Peptide Synthesizers (SPPS) market?
What factors are driving Solid Phase Peptide Synthesizers (SPPS) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Solid Phase Peptide Synthesizers (SPPS) market opportunities vary by end market size?
How does Solid Phase Peptide Synthesizers (SPPS) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Solid Phase Peptide Synthesizers (SPPS) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Solid Phase Peptide Synthesizers (SPPS) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Solid Phase Peptide Synthesizers (SPPS) by Country/Region, 2018, 2022 & 2029
2.2 Solid Phase Peptide Synthesizers (SPPS) Segment by Type
2.2.1 Automated
2.2.2 Semi-automatic
2.3 Solid Phase Peptide Synthesizers (SPPS) Sales by Type
2.3.1 Global Solid Phase Peptide Synthesizers (SPPS) Sales Market Share by Type (2018-2023)
2.3.2 Global Solid Phase Peptide Synthesizers (SPPS) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Solid Phase Peptide Synthesizers (SPPS) Sale Price by Type (2018-2023)
2.4 Solid Phase Peptide Synthesizers (SPPS) Segment by Application
2.4.1 Pharmaceutical Industry
2.4.2 Chemical Industry
2.4.3 Others
2.5 Solid Phase Peptide Synthesizers (SPPS) Sales by Application
2.5.1 Global Solid Phase Peptide Synthesizers (SPPS) Sale Market Share by Application (2018-2023)
2.5.2 Global Solid Phase Peptide Synthesizers (SPPS) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Solid Phase Peptide Synthesizers (SPPS) Sale Price by Application (2018-2023)
3 Global Solid Phase Peptide Synthesizers (SPPS) by Company
3.1 Global Solid Phase Peptide Synthesizers (SPPS) Breakdown Data by Company
3.1.1 Global Solid Phase Peptide Synthesizers (SPPS) Annual Sales by Company (2018-2023)
3.1.2 Global Solid Phase Peptide Synthesizers (SPPS) Sales Market Share by Company (2018-2023)
3.2 Global Solid Phase Peptide Synthesizers (SPPS) Annual Revenue by Company (2018-2023)
3.2.1 Global Solid Phase Peptide Synthesizers (SPPS) Revenue by Company (2018-2023)
3.2.2 Global Solid Phase Peptide Synthesizers (SPPS) Revenue Market Share by Company (2018-2023)
3.3 Global Solid Phase Peptide Synthesizers (SPPS) Sale Price by Company
3.4 Key Manufacturers Solid Phase Peptide Synthesizers (SPPS) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Solid Phase Peptide Synthesizers (SPPS) Product Location Distribution
3.4.2 Players Solid Phase Peptide Synthesizers (SPPS) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Solid Phase Peptide Synthesizers (SPPS) by Geographic Region
4.1 World Historic Solid Phase Peptide Synthesizers (SPPS) Market Size by Geographic Region (2018-2023)
4.1.1 Global Solid Phase Peptide Synthesizers (SPPS) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Solid Phase Peptide Synthesizers (SPPS) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Solid Phase Peptide Synthesizers (SPPS) Market Size by Country/Region (2018-2023)
4.2.1 Global Solid Phase Peptide Synthesizers (SPPS) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Solid Phase Peptide Synthesizers (SPPS) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Solid Phase Peptide Synthesizers (SPPS) Sales Growth
4.4 APAC Solid Phase Peptide Synthesizers (SPPS) Sales Growth
4.5 Europe Solid Phase Peptide Synthesizers (SPPS) Sales Growth
4.6 Middle East & Africa Solid Phase Peptide Synthesizers (SPPS) Sales Growth
5 Americas
5.1 Americas Solid Phase Peptide Synthesizers (SPPS) Sales by Country
5.1.1 Americas Solid Phase Peptide Synthesizers (SPPS) Sales by Country (2018-2023)
5.1.2 Americas Solid Phase Peptide Synthesizers (SPPS) Revenue by Country (2018-2023)
5.2 Americas Solid Phase Peptide Synthesizers (SPPS) Sales by Type
5.3 Americas Solid Phase Peptide Synthesizers (SPPS) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Solid Phase Peptide Synthesizers (SPPS) Sales by Region
6.1.1 APAC Solid Phase Peptide Synthesizers (SPPS) Sales by Region (2018-2023)
6.1.2 APAC Solid Phase Peptide Synthesizers (SPPS) Revenue by Region (2018-2023)
6.2 APAC Solid Phase Peptide Synthesizers (SPPS) Sales by Type
6.3 APAC Solid Phase Peptide Synthesizers (SPPS) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Solid Phase Peptide Synthesizers (SPPS) by Country
7.1.1 Europe Solid Phase Peptide Synthesizers (SPPS) Sales by Country (2018-2023)
7.1.2 Europe Solid Phase Peptide Synthesizers (SPPS) Revenue by Country (2018-2023)
7.2 Europe Solid Phase Peptide Synthesizers (SPPS) Sales by Type
7.3 Europe Solid Phase Peptide Synthesizers (SPPS) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Solid Phase Peptide Synthesizers (SPPS) by Country
8.1.1 Middle East & Africa Solid Phase Peptide Synthesizers (SPPS) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Solid Phase Peptide Synthesizers (SPPS) Revenue by Country (2018-2023)
8.2 Middle East & Africa Solid Phase Peptide Synthesizers (SPPS) Sales by Type
8.3 Middle East & Africa Solid Phase Peptide Synthesizers (SPPS) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Solid Phase Peptide Synthesizers (SPPS)
10.3 Manufacturing Process Analysis of Solid Phase Peptide Synthesizers (SPPS)
10.4 Industry Chain Structure of Solid Phase Peptide Synthesizers (SPPS)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Solid Phase Peptide Synthesizers (SPPS) Distributors
11.3 Solid Phase Peptide Synthesizers (SPPS) Customer
12 World Forecast Review for Solid Phase Peptide Synthesizers (SPPS) by Geographic Region
12.1 Global Solid Phase Peptide Synthesizers (SPPS) Market Size Forecast by Region
12.1.1 Global Solid Phase Peptide Synthesizers (SPPS) Forecast by Region (2024-2029)
12.1.2 Global Solid Phase Peptide Synthesizers (SPPS) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Solid Phase Peptide Synthesizers (SPPS) Forecast by Type
12.7 Global Solid Phase Peptide Synthesizers (SPPS) Forecast by Application
13 Key Players Analysis
13.1 Büchi AG
13.1.1 Büchi AG Company Information
13.1.2 Büchi AG Solid Phase Peptide Synthesizers (SPPS) Product Portfolios and Specifications
13.1.3 Büchi AG Solid Phase Peptide Synthesizers (SPPS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Büchi AG Main Business Overview
13.1.5 Büchi AG Latest Developments
13.2 AAPPTec
13.2.1 AAPPTec Company Information
13.2.2 AAPPTec Solid Phase Peptide Synthesizers (SPPS) Product Portfolios and Specifications
13.2.3 AAPPTec Solid Phase Peptide Synthesizers (SPPS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AAPPTec Main Business Overview
13.2.5 AAPPTec Latest Developments
13.3 CEM
13.3.1 CEM Company Information
13.3.2 CEM Solid Phase Peptide Synthesizers (SPPS) Product Portfolios and Specifications
13.3.3 CEM Solid Phase Peptide Synthesizers (SPPS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CEM Main Business Overview
13.3.5 CEM Latest Developments
13.4 Gyros Protein Technologies
13.4.1 Gyros Protein Technologies Company Information
13.4.2 Gyros Protein Technologies Solid Phase Peptide Synthesizers (SPPS) Product Portfolios and Specifications
13.4.3 Gyros Protein Technologies Solid Phase Peptide Synthesizers (SPPS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Gyros Protein Technologies Main Business Overview
13.4.5 Gyros Protein Technologies Latest Developments
13.5 Biotage
13.5.1 Biotage Company Information
13.5.2 Biotage Solid Phase Peptide Synthesizers (SPPS) Product Portfolios and Specifications
13.5.3 Biotage Solid Phase Peptide Synthesizers (SPPS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biotage Main Business Overview
13.5.5 Biotage Latest Developments
13.6 CSBio
13.6.1 CSBio Company Information
13.6.2 CSBio Solid Phase Peptide Synthesizers (SPPS) Product Portfolios and Specifications
13.6.3 CSBio Solid Phase Peptide Synthesizers (SPPS) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CSBio Main Business Overview
13.6.5 CSBio Latest Developments
14 Research Findings and Conclusion